Bausch + Lomb Corporation (BLCO)
NYSE: BLCO · Real-Time Price · USD
17.36
-0.09 (-0.52%)
Aug 20, 2026, 11:41 AM EDT - Market open
Bausch + Lomb Revenue
Bausch + Lomb had revenue of $1.39B in the quarter ending June 30, 2026, with 9.08% growth. This brings the company's revenue in the last twelve months to $6.00B, up 9.28% year-over-year. In the year 2025, Bausch + Lomb had annual revenue of $5.10B with 6.47% growth.
Revenue (ttm)
$6.00B
Revenue Growth
+9.28%
P/S Ratio
1.17
Revenue / Employee
$409,538
Employees
13,000
Market Cap
6.20B
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 5.10B | 310.00M | 6.47% |
| Dec 31, 2024 | 4.79B | 645.00M | 15.56% |
| Dec 31, 2023 | 4.15B | 378.00M | 10.03% |
| Dec 31, 2022 | 3.77B | 3.00M | 0.08% |
| Dec 31, 2021 | 3.77B | 353.00M | 10.35% |
| Dec 31, 2020 | 3.41B | -366.00M | -9.69% |
| Dec 31, 2019 | 3.78B | 113.00M | 3.08% |
| Dec 31, 2018 | 3.67B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Avantor | 6.56B |
| AptarGroup | 3.93B |
| MiniMed Group | 3.10B |
| Envista Holdings | 2.86B |
| Teleflex | 2.25B |
| ICU Medical | 2.16B |
| Merit Medical Systems | 1.58B |
| Stevanato Group | 1.40B |
BLCO News
- 14 days ago - Bausch + Lomb announces Board of Directors update - TheFly
- 14 days ago - Bausch + Lomb reaffirms FY26 revenue $5.44B-$5.54B, consensus $5.49B - TheFly
- 14 days ago - Bausch Health CEO Thomas J. Appio Joins Bausch + Lomb Board - PRNewsWire
- 14 days ago - Bausch + Lomb Announces Board of Directors Update, Reaffirms Guidance - Business Wire
- 17 days ago - Bausch + Lomb price target raised to $21 from $20 at H.C. Wainwright - TheFly
- 21 days ago - Bausch + Lomb price target raised to $23 from $21 at UBS - TheFly
- 22 days ago - Bausch + Lomb Earnings Call Transcript: Q2 2026 - Transcripts
- 22 days ago - Bausch + Lomb Earnings release: Q2 2026 - Filings